Executive Insights for Life Sciences Innovators

Executive Insights features conversations with visionary leaders shaping the future of biotech, pharma, medtech, diagnostics, and tools. Hear from CEOs, entrepreneurs, and investors about building companies, raising capital, and driving innovation. Whether you are growing a startup or scaling a global life sciences business, these candid discussions deliver the insights you need to succeed.

Executive Insights for Life Sciences Innovators is a science podcast hosted by GeneCoda® Executive Search, with 25 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

GeneCoda® Executive Search hosts Executive Insights for Life Sciences Innovators, a science show with 25 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  Executive Insights for Life Sciences Innovators

  Pawel Krysiak | Jaya Biosciences - Gene Therapy for Neurodegeneration

  Jun 30, 202635 min

  In this episode of Executive Insights for Life Sciences Innovators, Don Alexander speaks with Pawel Krysiak, President & CEO of Jaya Biosciences. Pawel discusses JayaBio’s work to develop CNS-directed gene therapies for genetically defined neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and frontotemporal dementia. The conversation explores JayaBio’s focus on lysosomal enzyme gene heterozygosity and how this approach may help identify patient subpopulations within diseases historically treated as broad, heterogeneous conditions. Pawel also shares perspective from more than 20 years across neurodegeneration, oncology, rare diseases, commercialization, market access, and company building, including lessons from orphan drug launches and the challenge of advancing differentiated science toward clinical development. This episode was streamed live on YouTube on June 29, 2026 . Learn more at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠genecoda.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠.

  ListenShow Notes
• 

  Executive Insights for Life Sciences Innovators

  David Pass | AltrixBio - Gut-Targeted Oral Therapy for Diabetes and Obesity

  Jun 16, 202621 min

  In this episode of Executive Insights for Life Sciences Innovators, Don Alexander speaks with David Pass, CEO and President of AltrixBio. David discusses AltrixBio’s work to advance AJN003, a once-daily, oral, gut-targeted therapeutic candidate being developed for type 2 diabetes, obesity, and related cardiometabolic conditions. The conversation explores how AltrixBio’s approach is inspired by the metabolic effects observed after bariatric surgery, and how a non-systemic oral therapy could address important gaps in today’s treatment landscape. David also shares perspective from more than 25 years across diabetes, obesity, cardiovascular disease, pharma, biotech, and digital health, including lessons from commercial leadership, company building, and advancing differentiated science toward the clinic. This episode was streamed live on YouTube on June 15, 2026 . Learn more at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠genecoda.com⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠.

  ListenShow Notes
• 

  Executive Insights for Life Sciences Innovators

  Dave Gallup | EMPIRI - Functional Precision Oncology and Live Tumor Tissue Drug Response

  May 30, 202630 minS0

  <p>In this episode of Executive Insights for Life Sciences Innovators, Don Alexander speaks with Dave Gallup, Co-Founder and CEO of EMPIRI, an oncology platform company advancing functional precision oncology through its E-slice platform.</p><p>Dave discusses how EMPIRI is using live human tumor tissue to measure drug response while preserving native tumor architecture and the tumor microenvironment. The conversation explores how E-slice may complement genomic and molecular profiling, help bridge the translational gap between preclinical models and clinical outcomes, and support better decision-making in oncology drug development.</p><p>Dave also shares his path from building biological analysis...

  ListenShow Notes
• 

  Executive Insights for Life Sciences Innovators

  Anil Goyal | IMMvention Therapeutix - Collaborations & Building Biotech Innovation Ecosystems

  May 19, 202633 minS0

  <p>In this episode of Executive Insights for Life Sciences Innovators, Don Alexander speaks with Dr. Anil Goyal, Co-Founder and CEO of IMMvention Therapeutix, a VC-backed biotechnology company developing globally accessible therapies for rare and chronic diseases, including sickle cell disease and Friedreich’s ataxia.</p><p>Anil shares insights from nearly 30 years in biotechnology leadership spanning company formation, fundraising, strategic partnerships, and therapeutic innovation across multiple modalities and disease areas. The conversation explores Immvention’s scientific approach, the realities of building emerging biotech companies in today’s funding environment, and the balance between scientific ambition and operational discipline.</p><p>They...

  ListenShow Notes
• 

  Executive Insights for Life Sciences Innovators

  Stan Watowich | Ridgeline Therapeutics - Targeting Aging Biology and Chronic Disease

  May 2, 202632 minS0

  <p>In this episode of Executive Insights for Life Sciences Innovators, Don Alexander speaks with Stan Watowich, Founder and CEO of Ridgeline Therapeutics and Professor of Biochemistry and Molecular Biology at the University of Texas Medical Branch.</p><p>Stan shares his journey from academic science to biotech company building, and how Ridgeline is developing small molecule therapies aimed at improving how we age and treat chronic disease. The conversation explores the company’s focus on NNMT, a key regulator of cellular energetics, and the broader opportunity to address age-linked conditions through targeted drug discovery.</p><p>They also discuss th...

  ListenShow Notes

Recent guests on Executive Insights for Life Sciences Innovators. Study who booked and why before you pitch.

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.